TransCure bioServices Revenue

Biotechnology Research • Archamps, Auvergne-Rhône-Alpes, France • 51-100 Employees

TransCure bioServices revenue & valuation

Annual revenue	$3,500,000
Revenue per employee	$47,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$11,200,000
Total funding	$2,800,000

Key Contacts at TransCure bioServices

Sebastien Tabruyn

Chief Executive Officer

Patrick Nef Phd

President & Chief Executive Officer

Company overview

Headquarters	260 avenue Marie-Curie, Archamps, France 74160 , FR
Phone number	+33480160142
Websites	transcurebioservices.com tcbiosciences.com
NAICS	541714
SIC	873
Keywords	CRO, Immuno-Oncology, Preclinical Studies, Pre-Clinical, Drug Profiling, Humanized Hiv Mouse Models, Humanized Ibd Mouse Models, Humanized Immune System Mouse Models, Infectious & Inflammatory Diseases, Predictive In Vivo Pharmacology, Humanized Mice
Founded	2012
Employees	51-100
Socials

TransCure bioServices Email Formats

TransCure bioServices uses 1 email format. The most common is {first name}.{last name} (e.g., john.doe@tcbioservices.com), used 100% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@tcbioservices.com	100%

About TransCure bioServices

Rethinking preclinical research - with your goals in mind. TransCure bioServices accelerates drug development by delivering the right models, the right data, with the right partnership mindset. Our advanced humanized mouse models provide robust, translational in vivo results to guide decision-making in: • Oncology (Human CDX, Human PDX, Syngeneic Models) • Inflammatory diseases (IBD, MASH, GvHD, Lung Inflammation) • Infectious diseases & toxicity (HIV, HBV, Immunotoxicity, Hepatotoxicity) You know your drug. We know how to test it. Every study is co-designed with your team to fit your strategy, timelines, and regulatory requirements-keeping you in control, while we handle the science. Located in France (near Geneva), our AAALAC-accredited, BSL-2 & BSL-3 facilities and expert staff ensure the highest standards of quality, safety, and animal welfare. We are committed to the 3Rs (Reduce, Refine, Replace), driving ethical and impactful science. With over 12 years’ experience and hundreds of completed studies, we proudly support biotech, pharma, and academic partners worldwide-from discovery to clinical readiness.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

C-Suite

Employees by Department

TransCure bioServices has 39 employees across 9 departments.

Departments

Number of employees

Funding Data

Explore TransCure bioServices's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2019-07-03	1	$2,800,000

Funding Insights

$2,800,000

Total funding amount

$2,800,000

Most recent funding amount

Number of funding rounds

TransCure bioServices Tech Stack

Discover the technologies and tools that power TransCure bioServices's digital infrastructure, from frameworks to analytics platforms.

Cloudflare Bot Management

Security

Smart Slider 3

WordPress plugins

Cookie Control

Cookie compliance

PWA

Miscellaneous

Google Maps

Maps

Animate.css

UI frameworks

Frequently asked questions

TransCure bioServices is located in Archamps, Auvergne-Rhône-Alpes, FR.

You can reach TransCure bioServices at +33480160142.

TransCure bioServices generates an estimated annual revenue of $3,500,000. This revenue figure reflects the company's market position and business performance in its industry.

TransCure bioServices has an estimated valuation of $11,200,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

TransCure bioServices was founded in 2012, making it 14 years old. The company has established itself as a significant player in its industry over this time.

TransCure bioServices has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

TransCure bioServices has raised a total of $2,800,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at TransCure bioServices

Sebastien Tabruyn

Chief Executive Officer

Patrick Nef Phd

President & Chief Executive Officer

4.8

40,000 users